Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,692,630
+$5,532,487 QoQ
Shares Held
3,589,863
+3.6% QoQ
Ownership
3.00%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 156 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. FATE ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in FATE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,692,630 | 3,589,863 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,160,143 | 3,466,786 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,699,382 | 1,734,064 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,134,953 | 900,757 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $255,813 | 228,405 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $191,078 | 241,872 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $490,224 | 297,106 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,608,477 | 459,565 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,345,557 | 1,019,987 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,945,100 | 265,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,799,464 | 1,550,659 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,500,696 | 1,651,272 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,127,514 | 1,917,545 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,277,573 | 1,803,083 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,172,837 | 1,503,750 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,236,991 | 189,067 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $860,097 | 14,700 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,753,854 | 299,542 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,435,979 | 293,075 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $54,382,618 | 659,583 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $29,310,558 | 322,342 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,745,892 | 368,924 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,444,000 | 216,963 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||